Blood Flow Restriction Following Hip Arthroscopy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and/or labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will take place at 1-month, 3-months, 6-months, and 1-year.
Epistemonikos ID: 83f7570764804cf3845a4f7afa6798b2496aedc0
First added on: May 22, 2024